9-125747475-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006195.6(PBX3):āc.22C>Gā(p.Leu8Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000099 in 1,576,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006195.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PBX3 | NM_006195.6 | c.22C>G | p.Leu8Val | missense_variant | 1/9 | ENST00000373489.10 | NP_006186.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PBX3 | ENST00000373489.10 | c.22C>G | p.Leu8Val | missense_variant | 1/9 | 1 | NM_006195.6 | ENSP00000362588.5 |
Frequencies
GnomAD3 genomes AF: 0.000418 AC: 63AN: 150618Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.000153 AC: 31AN: 202416Hom.: 0 AF XY: 0.000125 AC XY: 14AN XY: 111668
GnomAD4 exome AF: 0.0000652 AC: 93AN: 1425532Hom.: 0 Cov.: 32 AF XY: 0.0000579 AC XY: 41AN XY: 708620
GnomAD4 genome AF: 0.000418 AC: 63AN: 150618Hom.: 0 Cov.: 29 AF XY: 0.000394 AC XY: 29AN XY: 73542
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 12, 2024 | The c.22C>G (p.L8V) alteration is located in exon 1 (coding exon 1) of the PBX3 gene. This alteration results from a C to G substitution at nucleotide position 22, causing the leucine (L) at amino acid position 8 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at